Nicholas Laccona serves as Executive at Bellerophon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Nicholas Laccona has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 9, 2022 involved selling 5,530 shares valued at $5.1K.
Nicholas Laccona currently holds 12,470 shares of Bellerophon Therapeutics, Inc. (BLPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nicholas Laccona has been a net neutral trader of BLPH stock. They have purchased $0 and sold $0 worth of shares.
Nicholas Laccona's most recent insider trade was on Dec 9, 2022, when they sold 5,530 shares at $0.93 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |